CONGEN Biotechnologie

What CONGEN Biotechnologie does

CONGEN Biotechnologie GmbH is a privately held German biotechnology company founded in 1998 and headquartered at the Berlin-Buch science campus. It develops and manufactures real-time PCR-based detection kits for two end-markets: food analytics (allergens, GMOs, food microbiology including Salmonella, Listeria, E. coli/STEC, and Bacillus cereus, plus animal/plant species identification) and clinical diagnostics (nosocomial, respiratory, sexually transmitted, stool, periodontitis infections, plus companion diagnostics/precision medicine). The portfolio is organized under four sub-brands distributed globally by R-Biopharm AG — SureFood and SureFast for food analysis, and RIDA GENE and RIDA UNITY for clinical diagnostics — alongside the SureCycle system-verification kit and a custom PCR bead manufacturing line that has produced more than 5 million units for point-of-care platforms since 2020.

The company's core technology is real-time PCR for nucleic acid extraction, detection, and quantification; every assay is designed and validated in-house, with detection limits on sensitive kits at or below 5 DNA copies, and products are compatible with all standard real-time PCR instruments supporting at least FAM and VIC/HEX reporter dyes. Manufacturing is conducted under DIN ISO 13485 (medical devices) and ISO 9001 quality systems, and select SureFast kits have received AOAC-RI approval for STEC/E. coli serotyping, providing third-party validation in regulated markets.

CONGEN monetizes primarily through one-time sales of detection kits and PCR bead supply contracts, priced under undisclosed B2B terms with 14-day net payment. Distribution is handled almost exclusively by R-Biopharm worldwide, supplemented by a direct sales capability and a marketing mix spanning the company website, twice-yearly newsletter, LinkedIn presence, industry conferences (Analytica, Biofach, DVG, etc.), and scientific publications. In 2023 the company discontinued its ServiceLab testing-service offering and refocused on kit-based products; ownership remains concentrated with the founders, Dr. Steffen Mergemeier (Managing Director) and Matthias Kuhn, with no disclosed external institutional investors.

Name

CONGEN Biotechnologie

Legal name

CONGEN Biotechnologie GmbH

Website

https://congen.de

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

CONGEN Biotechnologie GmbH is a German developer and manufacturer of real-time PCR detection kits for food safety and clinical diagnostics, distributed globally via R-Biopharm under the SureFood, SureFast, RIDA GENE, and RIDA UNITY brands, plus custom PCR beads for point-of-care platforms.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA)

akta.pro secondary industries

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF), Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL), GMO/Non-GMO & Bioengineered Disclosure Verification (label compliance support) (AFALAHAH), “Free-From” & Allergen-Free Claim Substantiation (e.g., gluten-free, peanut-free) (AFALAHAD)

Keywords

• Real-time PCR kits
• Food safety testing
• Clinical diagnostics
• Nucleic acid extraction
• Molecular diagnostics

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Detection Kit Sales: Sale of real-time PCR detection kits for food analytics and clinical diagnostics. Products are sold directly and through distribution partner R-Biopharm under the SureFood, SureFast, RIDA GENE, and RIDA UNITY brands.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

CONGEN Biotechnologie GmbH develops and manufactures real-time PCR-based detection kits for nucleic acid analysis. The product portfolio is organized into two main lines: food analytics (under the SureFood® and SureFast® brands covering allergens, GMOs, microbiology, and animal/plant species) and clinical diagnostics (under the RIDA®GENE and RIDA®UNITY brands covering infectious diseases and personalized medicine). The company also produces PCR beads for point-of-care platforms and the SureCycle® system verification kit for real-time PCR instruments.

Product overview

CONGEN Biotechnologie develops and manufactures real-time PCR-based detection kits for food safety analytics and clinical diagnostics. The product portfolio is organized around four brand families distributed globally by R-Biopharm AG: SureFood® and SureFast® (food analysis), and RIDA®GENE and RIDA®UNITY (clinical diagnostics). SureFood® and SureFast® kits cover food allergens, GMOs, food microbiology (Salmonella, Listeria, E. coli/STEC, Bacillus cereus), animal species detection, and nucleic acid extraction via SureFast® PREP sample prep kits. The SureCycle® system verification product is a separate instrument QC tool. Clinical diagnostics products cover nosocomial infections, respiratory infections, sexually transmitted diseases, stool diagnostics, periodontitis, and companion diagnostics/precision medicine. CONGEN also manufactures PCR beads (>5 million units) for Point-of-Care diagnostic platforms. All products are based on real-time PCR technology and are compatible with standard real-time PCR instruments.

Differentiator

Problem solved

Functional benefit

Brands

• SureFood®: Brand name for food analysis products including allergen detection, GMO detection, food microbiology, and animal species detection kits.
• SureFast®
• RIDA®GENE
• RIDA®UNITY
• SureCycle®

Products and services

• SureFood® Real-time PCR Kits — Food Allergens
• SureFast® Real-time PCR Kits — Food Microbiology
• SureFast® Emetic Bacillus cereus PLUS
• SureFast® EHEC/EPEC 4plex
• SureFast® Escherichia coli Serotype I/II 4plex
• SureFast® PREP / SureFood® PREP Sample Preparation Kits
• SureFood® GMO Detection Kits
• SureFood® Animal Species Detection Kits
• RIDA®GENE Clinical Diagnostics Kits
• RIDA®UNITY Clinical Diagnostics Kits
• Companion Diagnostics / Precision Medicine Kits
• SureCycle® System Verification Kit
• PCR Beads for Point-of-Care Platforms

Quantifiable outcome

• Detection limit of <5 DNA copies for sensitive detection kits
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature7 records

Partnerships

Two partnerships are on record, tiered core.

• R-BiopharmcoreChannel Partner/ Reseller/ DistributorR-Biopharm serves as CONGEN's global distribution partner, distributing CONGEN products worldwide under the brand names SureFood, SureFast, RIDA GENE, and RIDA UNITY.
• R-Biopharm (Product Distribution)coreChannel Partner/ Reseller/ DistributorProducts distributed through R-Biopharm network for global reach in food analytics and clinical diagnostics markets.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• ELITech Group: Specialized IVD company producing PCR-based diagnostic kits for infectious disease (respiratory, STI, hospital-acquired infections) sold to clinical labs. Closely comparable in clinical real-time PCR kit focus and target customer profile.
• R-Biopharm AG: Global distribution partner for CONGEN's kits (SureFood, SureFast, RIDA GENE, RIDA UNITY) and itself a developer of PCR-based food and clinical diagnostic kits. Highly comparable in product, technology, and customer base; the two companies are simultaneously channel partner and competitor.
• Hygiena (Hygiena LLC): Specialist in rapid food safety and microbiological testing, including PCR-based pathogen detection kits (e.g., BAX System). Directly competes in food microbiology molecular detection with overlapping customer types (food manufacturers and QC labs).

Emerging players

• Mobidiag (Hologic): Develops multiplex molecular diagnostic tests for infectious diseases (Amplidiag, Novodiag), now part of Hologic. Comparable in multiplex PCR assay design and clinical microbiology end markets, though with stronger isothermal platform presence.

Broad incumbents

• bioMérieux SA: Global leader in microbiological diagnostics, including PCR-based food pathogen detection (e.g., GENE-UP, BioBall) and clinical infectious disease IVD. Operates in the same end markets (food safety labs, clinical labs) with overlapping molecular technology.
• Thermo Fisher Scientific: Through Applied Biosystems and MicroSEQ brands, offers a comprehensive portfolio of real-time PCR kits, instruments, and food/pharmaceutical testing consumables. Comparable in PCR chemistry and broad regulatory footprint.
• Neogen Corporation (formerly 3M Food Safety): Provides molecular and immunoassay-based food pathogen detection kits (e.g., NeoSeek, Soleris) and a broad food safety product portfolio. Comparable in food microbiology detection and quality control lab customer overlap.
• QIAGEN N.V. Provider of sample preparation kits, PCR reagents, and complete molecular diagnostic workflows for infectious disease, food, and veterinary testing. Comparable in nucleic acid extraction (SureFast PREP equivalent) and PCR consumables.
• Bio-Rad Laboratories: Major manufacturer of real-time PCR instruments and diagnostic kits (e.g., ddPCR, iQ-Check pathogen detection kits for food). Directly comparable PCR technology stack and food microbiology / clinical diagnostics customer base.

Others

• Eurofins Scientific: Largest global food testing services network with substantial in-house method development. A major buyer-side counterpart for CONGEN's kits and a comparable player at the food analytics/PCR workflow level, though structured as a services business.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInde.linkedin.com/company/congen

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CONGEN Biotechnologie